These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7525922

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Amido analogs of mitoxantrone: physico-chemical properties, molecular modeling, cellular effects and antineoplastic potential.
    Zagotto G, Moro S, Uriarte E, Ferrazzi E, Palù G, Palumbo M.
    Anticancer Drug Des; 1997 Mar; 12(2):99-112. PubMed ID: 9113065
    [Abstract] [Full Text] [Related]

  • 23. Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase.
    Ng SF, Waxman DJ.
    Cancer Res; 1990 Feb 01; 50(3):464-71. PubMed ID: 2105156
    [Abstract] [Full Text] [Related]

  • 24. In the search for new anticancer drugs. 13. Phosphonic and phosphinic analogues of ornithine.
    Sosnovsky G, Lukszo J, Gravela E, Zuretti MF.
    J Med Chem; 1985 Sep 01; 28(9):1350-4. PubMed ID: 4032436
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [The structure of products of modification of nucleotides and DNA by ethyleneimine and thio-TEPA].
    Serebrianyĭ AM, Andrievskiĭ GV, Bekker AR, Sibel'dina LA, Sharova OL.
    Bioorg Khim; 1987 Jun 01; 13(6):786-92. PubMed ID: 3118884
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Novel seleno- and thio-urea derivatives with potent in vitro activities against several cancer cell lines.
    Alcolea V, Plano D, Karelia DN, Palop JA, Amin S, Sanmartín C, Sharma AK.
    Eur J Med Chem; 2016 May 04; 113():134-44. PubMed ID: 26922233
    [Abstract] [Full Text] [Related]

  • 31. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
    Burres NS, Clement JJ.
    Cancer Res; 1989 Jun 01; 49(11):2935-40. PubMed ID: 2720652
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
    Tsuruo T, Oh-Hara T, Sudo Y, Naito M.
    Anticancer Res; 1993 Jun 01; 13(2):357-61. PubMed ID: 8517647
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics of thio-TEPA and TEPA in the conventional dose-range and its correlation to myelosuppressive effects.
    Hagen B.
    Cancer Chemother Pharmacol; 1991 Jun 01; 27(5):373-8. PubMed ID: 1705489
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Cytotoxic liponucleotide analogs. II. Antitumor activity of CDP-diacylglycerol analogs containing the cytosine arabinoside moiety.
    Turcotte JG, Srivastava SP, Steim JM, Calabresi P, Tibbetts LM, Chu MY.
    Biochim Biophys Acta; 1980 Sep 08; 619(3):619-31. PubMed ID: 7459369
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.